Improvement in glucose tolerance and insulin sensitivity by probiotic strains of Indian gut origin in high-fat diet-fed C57BL/6J mice

European Journal of Nutrition

Volumn 57, Issue 1, 2018, Pages 279-295

  Balakumar, Mahalingam ^a   Prabhu, Durai ^a   Sathishkumar, Chandrakumar ^a   Prabu, Paramasivam ^a   Rokana, Namita ^b   Kumar, Ramesh ^a   Raghavan, Srividhya ^a   Soundarajan, Avinash ^a   Grover, Sunita ^b   Batish, Virender Kumar ^b   Mohan, Viswanathan ^a   Balasubramanyam, Muthuswamy ^a  

^a MADRAS DIABETES RESEARCH FOUNDATION   (India)

^b NATIONAL DAIRY RESEARCH INSTITUTE   (India)

Author keywords

High fat diet; Insulin resistance; Lactobacillus fermentum MTCC 5689; Lactobacillus plantarum MTCC 5690; LGG; LPS; Probiotics; Tight junction protein; Type 2 diabetes

Indexed keywords

ADIPONECTIN; CHOLESTEROL; GLUCAGON LIKE PEPTIDE 1; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN; INSULIN; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; LOW DENSITY LIPOPROTEIN; MESSENGER RNA; METFORMIN; OCCLUDIN; PROBIOTIC AGENT; PROTEIN ZO1; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR; VILDAGLIPTIN; LIPID; TRANSCRIPTOME;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL STRAIN; BIOCHEMICAL ANALYSIS; C57BL 6 MOUSE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIABETES MELLITUS; ENDOTOXEMIA; GENE EXPRESSION PROFILING; GENETIC TRANSCRIPTION; GLUCONEOGENESIS; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE; INFLAMMATION; INSULIN RESISTANCE; INSULIN SENSITIVITY; INSULIN TOLERANCE TEST; INTESTINE FLORA; INTESTINE MUCOSA PERMEABILITY; INTRA-ABDOMINAL FAT; LACTOBACILLUS FERMENTUM; LACTOBACILLUS PLANTARUM; LACTOBACILLUS RHAMNOSUS; LIPID DIET; LIPID HOMEOSTASIS; LIPOGENESIS; LIVER; MALE; MOUSE; NONHUMAN; ORAL GLUCOSE TOLERANCE TEST; REAL TIME POLYMERASE CHAIN REACTION; SKELETAL MUSCLE; SMALL INTESTINE TISSUE; STRAIN DIFFERENCE; TRIACYLGLYCEROL BLOOD LEVEL; ANALYSIS; ANIMAL; BLOOD; C57BL MOUSE; DYSLIPIDEMIA; ENDOPLASMIC RETICULUM STRESS; EXPERIMENTAL DIABETES MELLITUS; GENETICS; INDIA; NON INSULIN DEPENDENT DIABETES MELLITUS;

ANIMALS; BLOOD GLUCOSE; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 2; DIET, HIGH-FAT; DYSLIPIDEMIAS; ENDOPLASMIC RETICULUM STRESS; GASTROINTESTINAL MICROBIOME; GLUCAGON-LIKE PEPTIDE 1; GLUCONEOGENESIS; GLUCOSE INTOLERANCE; INDIA; INFLAMMATION; INSULIN RESISTANCE; LACTOBACILLUS FERMENTUM; LACTOBACILLUS PLANTARUM; LIPIDS; LIPOGENESIS; LIPOPOLYSACCHARIDES; MALE; MICE; MICE, INBRED C57BL; PROBIOTICS; TRANSCRIPTOME;

EID: 84991578379     PISSN: 14366207     EISSN: 14366215     Source Type: Journal    
DOI: 10.1007/s00394-016-1317-7     Document Type: Article

References (58)

1. Anjana RM, Pradeepa R, Deepa M, Datta M, Sudha V, Unnikrishnan R, Bhansali A, Joshi SR, Joshi PP, Yajnik CS, Dhandhania VK, Nath LM, Das AK, Rao PV, Madhu SV, Shukla DK, Kaur T, Priya M, Nirmal E, Parvathi SJ, Subhashini S, Subashini R, Ali MK, Mohan V, Group II (2011) Prevalence of diabetes and prediabetes (impaired fasting glucose and/or impaired glucose tolerance) in urban and rural India: phase I results of the Indian Council of Medical Research- INdiaDIABetes (ICMR-INDIAB) study. Diabetologia 54:3022–3027. doi:10.1007/s00125-011-2291-5
2. Mohan V, Sudha V, Radhika G, Radha V, Rema M, Deepa R (2007) Gene-environment interactions and the diabetes epidemic in India. Forum Nutr 60:118–126. doi:10.1159/0000107088
3. Cani PD, Bibiloni R, Knauf C, Waget A, Neyrinck AM, Delzenne NM, Burcelin R (2008) Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes 57:1470–1481. doi:10.2337/db07-1403
4. FAO/WHO (2002) Working Group Report on Drafting Guidelines for the Evaluation of Probiotics in Food London, Ontario, Canada
5. Yadav H, Jain S, Sinha PR (2007) Antidiabetic effect of probiotic dahi containing Lactobacillus acidophilus and Lactobacillus casei in high fructose fed rats. Nutrition (Burbank, Los Angeles County, Calif.) 23:62–68. doi:10.1016/j.nut.2006.09.002
6. Matsuzaki T, Nagata Y, Kado S, Uchida K, Kato I, Hashimoto S, Yokokura T (1997) Prevention of onset in an insulin-dependent diabetes mellitus model, NOD mice, by oral feeding of Lactobacillus casei. Actapathol Microbiol Immunol Scand 105:643–649
7. Kadooka Y, Sato M, Imaizumi K, Ogawa A, Ikuyama K, Akai Y, Okano M, Kagoshima M, Tsuchida T (2010) Regulation of abdominal adiposity by probiotics (Lactobacillus gasseri SBT2055) in adults with obese tendencies in a randomized controlled trial. Euro J Clin Nutr 64:636–643. doi:10.1038/ejcn.2010.19
8. Cani PD, Lecourt E, Dewulf EM, Sohet FM, Pachikian BD, Naslain D, De Backer F, Neyrinck AM, Delzenne NM (2009) Gut microbiota fermentation of prebiotics increases satietogenic and incretin gut peptide production with consequences for appetite sensation and glucose response after a meal. Am J Clin Nutr 90:1236–1243. doi:10.3945/ajcn.2009.28095
9. Kaji I, Karaki S-I, Tanaka R, Kuwahara A (2011) Density distribution of free fatty acid receptor 2 (FFA2)-expressing and GLP-1-producing enteroendocrine L cells in human and rat lower intestine, and increased cell numbers after ingestion of fructo-oligosaccharide. J Mol Histol 42:27–38. doi:10.1007/s10735-010-9304-4
10. Simon M-CC, Strassburger K, Nowotny B, Kolb H, Nowotny P, Burkart V, Zivehe F, Hwang J-HH, Stehle P, Pacini G, Hartmann B, Holst JJ, MacKenzie C, Bindels LB, Martinez I, Walter J, Henrich B, Schloot NC, Roden M (2015) Intake of Lactobacillus reuteri improves incretin and insulin secretion in glucose-tolerant humans: a proof of concept. Diabetes Care 38:1827–1834. doi:10.2337/dc14-2690
11. Grover S, Sharma VK, Mallapa RH, Batish VK (2013) Draft Genome Sequence of Lactobacillus fermentum Lf1, an Indian isolate of human gut origin. Genome Announc 14(1(6)): pii: e00883–13. doi: 10.1128/genomeA.00883-13
12. Grover S, Sharma VK, Mallapa RH, Batish VK (2013) Draft genome sequence of lactobacillus plantarum strain Lp91, a promising Indian probiotic isolate of human gut origin. Genome Announc 21;1(6): pii:e00976–13. doi:10.1128/genomeA.00976-13
13. Kumar R, Grover S, Batish VK (2011) Hypocholesterolaemic effect of dietary inclusion of two putative probiotic bile salt hydrolase-producing Lactobacillus plantarum strains in Sprague-Dawley rats. Br J Nutr 105:561–573. doi:10.1017/S0007114510003740
14. Duary RK, Rajput YS, Batish VK, Grover S (2011) Assessing the adhesion of putative indigenous probiotic lactobacilli to human colonic epithelial cells. Indian J Med Res 134:664–671. doi:10.4103/0971-5916.90992
15. Duary RK, Bhausaheb MA, Batish VK, Grover S (2012) Anti-inflammatory and immunomodulatory efficacy of indigenous probiotic Lactobacillus plantarum Lp91 in colitis mouse model. Mol Biol Rep 39:4765–4775
16. Chandran A, Duary RK, Grover S, Batish VK (2013) Relative expression of bacterial and host specific genes associated with probiotic survival and viability in the mice gut fed with Lactobacillus plantarum Lp91. Microbiol Res 168:555–562
17. AparnaSudhakaran V, Panwar H, Chauhan R, Duary RK, Rathore RK, Batish VK, Grover S (2013) Modulation of anti-inflammatory response in lipopolysaccharide stimulated human THP-1 cell line and mouse model at gene expression level with indigenous putative probiotic lactobacilli. Genes Nutr 8:637–648
18. Chauhan R, Vasanthakumari AS, Panwar H, Mallapa RH, Duary RK, Batish VK, Grover SC (2014) Amelioration of colitis in mouse model by exploring antioxidative potentials of an indigenous probiotic strain of Lactobacillus fermentum Lf1. BioMed Res Int 2014:206732
19. Whiting MJ, Shephard MD, Tallis GA (1997) Measurement of plasma LDL cholesterol in patients with diabetes. Diabetes Care 20:12–14
20. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412–419
21. Zhang JQ, Gao CR, Huang QL (1997) Determination of insulin sensitivity by short insulin tolerance test using capillary blood glucose. Chin J Endocrinol Metab 13:77–80
22. Srinivasan K, Patole PS, Kaul CL, Ramarao P (2004) Reversal of glucose intolerance by pioglitazone in high fat diet-fed rats. Methods Find Exp Clin Pharmacol 26:327–333
23. Wang Q, Fang CH, Hasselgren PO (2001) Intestinal permeability is reduced and IL-10 levels are increased in septic IL-6 knockout mice. Am J Physiol Regul Integr Comp Physiol 281:23
24. Balasubramanyam M, Aravind S, Gokulakrishnan K, Prabu P, Sathishkumar C, Ranjani H, Mohan V (2011) Impaired miR-146a expression links subclinical inflammation and insulin resistance in Type 2 diabetes. Mol Cell Biochem 351:197–205. doi:10.1007/s11010-011-0727-3
25. Karimi G, Sabran MR, Jamaluddin R, Parvaneh K, Mohtarrudin N, Ahmad Z, Khazaai H, Khodavandi A (2015) The anti-obesity effects of Lactobacillus casei strain Shirota versus Orlistat on high fat diet-induced obese rats. Food Nutr Res 59:29273. doi:10.3402/fnr.v59.29273
26. Hsieh F-CC, Lee C-LL, Chai C-YY, Chen W-TT, Lu Y-CC, Wu C-SS (2013) Oral administration of Lactobacillus reuteri GMNL-263 improves insulin resistance and ameliorates hepatic steatosis in high fructose-fed rats. Nutr Metab 10:35. doi:10.1186/1743-7075-10-35
27. Ooi L-GG, Liong M-TT (2010) Cholesterol-lowering effects of probiotics and prebiotics: a review of in vivo and in vitro findings. Int J Mol Sci 11:2499–2522. doi:10.3390/ijms11062499
28. Corcos M, Guilbaud O, Paterniti S, Moussa M, Chambry J, Chaouat G, Consoli SM, Jeammet P (2003) Involvement of cytokines in eating disorders: a critical review of the human literature. Psychoneuroendocrinology 28:229–249
29. Kim K-AA, Gu W, Lee I-AA, Joh E-HH, Kim D-HH (2012) High fat diet-induced gut microbiota exacerbates inflammation and obesity in mice via the TLR4 signaling pathway. PloS One 7. doi:10.1371/journal.pone.0047713
30. Cani PD, Amar J, Iglesias MA, Poggi M, Knauf C, Bastelica D, Neyrinck AM, Fava F, Tuohy KM, Chabo C, Waget A, Delmée E, Cousin B, Sulpice T, Chamontin B, Ferrières J, Tanti J-FF, Gibson GR, Casteilla L, Delzenne NM, Alessi MC, Burcelin R (2007) Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 56:1761–1772. doi:10.2337/db06-1491
31. Everard A, Cani PD (2013) Diabetes, obesity and gut microbiota. Best practice & research. Clin Gastroenterol 27:73–83. doi:10.1016/j.bpg.2013.03.007
32. Jayashree B, Bibin YS, Prabhu D, Shanthirani CS, Gokulakrishnan K, Lakshmi BS, Mohan V, Balasubramanyam M (2014) Increased circulatory levels of lipopolysaccharide (LPS) and zonulin signify novel biomarkers of proinflammation in patients with type 2 diabetes. Mol Cell Biochem 388:203–210. doi:10.1007/s11010-013-1911-4
33. Naito E, Yoshida Y, Makino K, Kounoshi Y, Kunihiro S, Takahashi R, Matsuzaki T, Miyazaki K, Ishikawa F (2011) Beneficial effect of oral administration of Lactobacillus casei strain Shirota on insulin resistance in diet-induced obesity mice. J Appl Microbiol 110:650–657. doi:10.1111/j.1365-2672.2010.04922.x
34. Amar J, Chabo C, Waget A, Klopp P, Vachoux C, Bermúdez-Humarán LG, Smirnova N, Bergé M, Sulpice T, Lahtinen S, Ouwehand A, Langella P, Rautonen N, Sansonetti PJ, Burcelin R (2011) Intestinal mucosal adherence and translocation of commensal bacteria at the early onset of type 2 diabetes: molecular mechanisms and probiotic treatment. EMBO Mol Med 3:559–572. doi:10.1002/emmm.201100159
35. D’Alessio DA, Denney AM, Hermiller LM, Prigeon RL, Martin JM, Tharp WG, Saylan ML, He Y, Dunning BE, Foley JE, Pratley RE (2009) Treatment with the dipeptidyl peptidase-4 inhibitor vildagliptin improves fasting islet-cell function in subjects with type 2 diabetes. J Clin Endocrinol Metab 94:81–88. doi:10.1210/jc.2008-1135
36. Mannucci E, Tesi F, Bardini G, Ognibene A, Petracca MG, Ciani S, Pezzatini A, BrogiM Dicembrini I, Cremasco F, Messeri G, Rotella CM (2004) Effects of metformin on glucagon-like peptide-1 levels in obese patients with and without Type 2 diabetes. Diab Nutr Metab 17:336–342
37. Lim GE, Huang GJ, Flora N, LeRoith D, Rhodes CJ, Brubaker PL (2009) Insulin regulates glucagon-like peptide-1 secretion from the enteroendocrine L cell. Endocrinology 150:580–591. doi:10.1210/en.2008-0726
38. Stenman LK, Waget A, Garret C, Briand F, Burcelin R, Sulpice T, Lahtinen S (2015) Probiotic B420 and prebiotic polydextrose improve efficacy of antidiabetic drugs in mice. Diabetol Metab Syndr 7:75. doi:10.1186/s13098-015-0075-7
39. Wong JM, de Souza R, Kendall CW, Emam A, Jenkins DJ (2006) Colonic health: fermentation and short chain fatty acids. J Clin Gastroenterol 40:235–243
40. S-i Karaki, Mitsui R, Hayashi H, Kato I, Sugiya H, Iwanaga T, Furness JB, Kuwahara A (2006) Short-chain fatty acid receptor, GPR43, is expressed by enteroendocrine cells and mucosal mast cells in rat intestine. Cell Tissue Res 324:353–360. doi:10.1007/s00441-005-0140-x
41. Pereira DI, Gibson GR (2002) Effects of consumption of probiotics and prebiotics on serum lipid levels in humans. Crit Rev Biochem Mol Biol 37:259–281. doi:10.1080/10409230290771519
42. Qin J, Li Y, Cai Z, Li S, Zhu J, Zhang F, Liang S, Zhang W, Guan Y, Shen D, Peng Y, Zhang D, Jie Z, Wu W, Qin Y, Xue W, Li J, Han L, Lu D, Wu P, Dai Y, Sun X, Li Z, Tang A, Zhong S, Li X, Chen W, Xu R, Wang M, Feng Q, Gong M, Yu J, Zhang Y, Zhang M, Hansen T, Sanchez G, Raes J, Falony G, Okuda S, Almeida M, LeChatelier E, Renault P, Pons N, Batto J-MM, Zhang Z, Chen H, Yang R, Zheng W, Li S, Yang H, Wang J, Ehrlich SD, Nielsen R, Pedersen O, Kristiansen K, Wang J (2012) A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature 490:55–60. doi:10.1038/nature11450
43. Forslund K, Hildebrand F, Nielsen T, Falony G, Le Chatelier E, Sunagawa S, Prifti E, Vieira-Silva S, Gudmundsdottir V, Krogh Pedersen H, Arumugam M, Kristiansen K, Voigt AY, Vestergaard H, Hercog R, Igor Costea P, Kultima JR, Li J, Jørgensen T, Levenez F, Dore J, consortium M, Nielsen HB, Brunak S, Raes J, Hansen T, Wang J, Ehrlich SD, Bork P, Pedersen O (2015) Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota. Nature 528:262–266. doi:10.1038/nature15766
44. Mandard S, Zandbergen F, van Straten E, Wahli W, Kuipers F, Müller M, Kersten S (2006) The fasting-induced adipose factor/angiopoietin-like protein 4 is physically associated with lipoproteins and governs plasma lipid levels and adiposity. J Biol Chem 281:934–944. doi:10.1074/jbc.M506519200
45. Shen J, Obin MS, Zhao L (2013) The gut microbiota, obesity and insulin resistance. Mol Aspects Med 34:39–58. doi:10.1016/j.mam.2012.11.001
46. Bäckhed F, Manchester JK, Semenkovich CF, Gordon JI (2007) Mechanisms underlying the resistance to diet-induced obesity in germ-free mice. Proc Natl Acad Sci USA 104:979–984. doi:10.1073/pnas.0605374104
47. Aronsson L, Huang Y, Parini P, Korach-André M, Håkansson J, Gustafsson J-ÅÅ, Pettersson S, Arulampalam V, Rafter J (2010) Decreased fat storage by Lactobacillus paracasei is associated with increased levels of angiopoietin-like 4 protein (ANGPTL4). PloS One 5. doi:10.1371/journal.pone.0013087
48. Kim SW, Park KY, Kim B, Kim E, Hyun CK (2013) Lactobacillus rhamnosus GG improves insulin sensitivity and reduces adiposity in high-fat diet-fed mice through enhancement of adiponectin production. Biochem Biophys Res Commun 431:258–263. doi:10.1016/j.bbrc.2012.12.121
49. Flamment M, Hajduch E, Ferré P, Foufelle F (2012) New insights into ER stress-induced insulin resistance. Trend Endocrinol Metab 23:381–390. doi:10.1016/j.tem.2012.06.003
50. Lenin R, Sankaramoorthy A, Mohan V, Balasubramanyam M (2015) Altered immunometabolism at the interface of increased endoplasmic reticulum (ER) stress in patients with type 2 diabetes. J Leukocyte Biol 98:615–622. doi:10.1189/jlb.3A1214-609R
51. Park KY, Kim B, Hyun CK (2015) Lactobacillus rhamnosus GG improves glucose tolerance through alleviating ER stress and suppressing macrophage activation in db/db mice. J Clin Biochem Nutr 56:240–246. doi:10.3164/jcbn.14-116
52. Bleau C, Karelis AD, St-Pierre DH, Lamontagne L (2015) Crosstalk between intestinal microbiota, adipose tissue and skeletal muscle as an early event in systemic low-grade inflammation and the development of obesity and diabetes. Diabetes Metab Res Rev 31:545–561. doi:10.1002/dmrr.2617
53. Yoo SR, Kim YJ, Park DY, Jung UJ, Jeon SM, Ahn YT, Huh CS, McGregor R, Choi MS (2013) Probiotics L. plantarum and L. curvatus in combination alter hepatic lipid metabolism and suppress diet-induced obesity. Obesity (Silver Spring) 21:2571–2578. doi:10.1002/oby.20428
54. Firouzi S, Majid HA, Ismail A, Kamaruddin NA, Barakatun-Nisak M-YY (2016) Effect of multi-strain probiotics (multi-strain microbial cell preparation) on glycemic control and other diabetes-related outcomes in people with type 2 diabetes: a randomized controlled trial. Eur J Nutr. doi:10.1007/s00394-016-1199-8
55. Rajkumar H, Kumar M, Das N, Kumar SN, Challa HR, Nagpal R (2015) Effect of probiotic lactobacillussalivarius UBL S22 and prebiotic fructo-oligosaccharide on serum lipids, inflammatory markers, insulin sensitivity, and gut bacteria in healthy young volunteers: a randomized controlled single-blind pilot study. J Cardiovascularpharmacol Therap 20:289–298
56. Sun J, Buys NJ (2016) Glucose- and glycemic factor lowering effects of probiotics on diabetes: a meta-analysis of randomisedplacebo-controlled trials. Br J Nutr 115:1167–1177
57. Tonucci LB, Olbrich Dos Santos KM, Licursi de Oliveira L, Rocha Ribeiro SM, Duarte Martino HS (2015) Clinical application of probiotics in type 2 diabetes mellitus: A randomized, double-blind, placebo-controlled study. Clin Nutr. doi:10.1016/j.clnu.2015.11.011
58. Sáez-Lara MJ, Robles-Sanchez C, Ruiz-Ojeda FJ, Plaza-Diaz J, Gil A (2016) Effects of probiotics and synbiotics on obesity, insulin resistance syndrome, type 2 diabetes and non-alcoholic fatty liver disease: a review of human clinical trials. Int J Mol Sci 13;17: pii: E928. doi:10.3390/ijms17060928